If left untreated, pheochromocytoma may lead to hypertensive encephalopathy, cardiomyopathy, diabetes mellitus and even death – therefore adequate treatment should be pursued as soon as the correct diagnosis is established. Surgery is the primary and only valid approach, but a premedication step has to be undertaken prior to the procedure.
Medical preparation for surgery …show more content…
If the patient is not properly prepared, surgical resection of pheochromocytoma is associated with high mortality rates.
The most important issue is adequate blood pressure control in order to avoid potential hypertensive crisis during intraoperative handling of the tumor, maintain stable blood pressure during surgery, but also to minimize any adverse effects of anesthesia.
Usually the pretreatment begins with α-blockers, and when suitable α-blockade is achieved, the patient can then be treated with β-blockers to achieve adequate control of the heart rate. Phenoxybenzamine, which is a nonselective α-blocker, is a drug of choice (albeit doxazosin or prazosin can also be used). It is administrated 7 to 10 days before surgery.
Β-blockers can be used only after α-blockade, otherwise the initial use of β-blockers results in unopposed stimulating activity of catecholamines on α-receptors, leading to life-threatening hypertensive crisis. Usually 10 mg of propranolol four times a day is used for β-blockade, which is later translated to daily long-acting
dose.
There is also an option of using calcium channel blockers alone instead of α- and β-blockers, which can be an option in low-risk patients with additional benefit of not interfering with plasma metanephrine assays. By using these drugs, hypotension or orthostatic hypotension can be avoided during the normotensive period.
With appropriate preoperative α-blockade, anesthesia should not be more hazardous than in patients with a non-functioning adrenal tumor; nevertheless, in certain patients dramatic changes in blood pressure and heart rate may occur, which requires immediate administration of pressor or vasodilator agents.
Surgical approach
The most commonly used procedure for a majority of pheochromocytomas is laparoscopic adrenalectomy (either by transperitoneal or retroperitoneal approach), regardless of whether the disease is familial or sporadic. Preoperative biopsy is not indicated, as it is deemed potentially hazardous for the patient.
In patients with large tumors or when underlying malignancy is suspected based upon the clinical or radiographic presentation, laparotomy should be considered. If there is a need for bilateral procedure, the use of posterior retroperitoneoscopic surgery does not alter patient position during the operation, which results in a shorter operating period.
Immediately after the surgery, low blood pressure or hypotension is a common problem, which can be effectively managed with intravenous fluids (as vascular bed is basically paralyzed by medications used preoperatively). Accordingly, volume replacement can be ample during initial 24-36 hours.
Long-term prognosis
Removal of the adrenal tumor usually cures the high blood pressure, although up to 30 percent of patients may remain hypertensive even after the surgery. There is a general consensus that biochemical testing should be repeated 14 days after the surgery to probe for any remaining disease.
During long-term follow-up approximately 17% of tumor reappear (and half of them with signs of malignancy). Even though follow-up is particularly important for patients harboring mutations of disease-causing genes, no method is currently on our disposal to rule out potential for recurrence or malignancy; hence periodic long-term follow-up is recommended for all cases of pheochromocytoma.